Figure 3
Rate of clinical relevant improvement in HRQoL within 8 months in prespecified subgroups. CI, confidence interval; CRT, cardiac resynchronization therapy; GFR, glomerular filtration rate; HRQoL, health related quality of life; ICD, implantable cardioverter defibrillator; LV, left ventricular; NT-proBNP, N-terminal pro-brain natriuretic peptide; NYHA, New York Heart Association.

Rate of clinical relevant improvement in HRQoL within 8 months in prespecified subgroups. CI, confidence interval; CRT, cardiac resynchronization therapy; GFR, glomerular filtration rate; HRQoL, health related quality of life; ICD, implantable cardioverter defibrillator; LV, left ventricular; NT-proBNP, N-terminal pro-brain natriuretic peptide; NYHA, New York Heart Association.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close